USP7 and ovarian cancer: Qin et al. reported that in ovarian cancer bardoxolone methyl acts as a selective inhibitor of deubiquitinating enzyme ubiquitin-specific protease 7 (USP7), which is known to be a critical regulator in the oncogenic processes of numerous malignancies.